Private Equity, Venture Capital Flows To Biotechnology Lowest Since 2019
In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...
Dare Bioscience risks Nasdaq delisting over market value
SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...